von Willebrand Disease
Webinar on «Troubles de la coagulation chez la femme, hormones et COVID-19: Mise à jour et nouveautés!»
Thursday, 2nd September 2021, 17:00 - 19:00
Receive 2 CME-credits from the SGGG.
Download: Programm
Access to the recorded webinar: Link
Contact:
For additional questions please contact:
Dr. Caroline von Achenbach
caroline.vonachenbach@cslbehring.com
+41 (0)79 433 65 62
References:
1. Fraser IS et al. Prevalence of heavy menstrual bleeding and experiences of affected women in a Europeanpatient survey. Int J Gynaecol Obstet. 2015;128:196-200. 2. Hapangama DK et al. Pathophysiology of Heavy Menstrual Bleeding.Womens Health (Lond). 2016;12(1):3-13. 3. Byams VRl. Women with Bleeding Disorders. J Womens Health. 2007;16:1249-1251.4. James AH. Von Willebrand Disease in Women: Awareness and Diagnosis. Thromb Res. 2009;124:7-10. 5. Munoz M et al.Patient blood management in obstetrics. Transfus Med. 2018 Feb;28(1):22-39. 6. Surbek D et al. Patient blood management(PBM) in pregnancy and childbirth: literature review and expert opinion. Arch Gynecol and Obstet. 2020;301:627-641.7. Pirhadi R et al. Could estrogen protect women from COVID-19? J Clin Med Res. 2020;12(10):634-639.